The threat or risk factors associated with vaccine products have proven to be a challenge to human health. Since the emergence of COVID-19, various health institutions, with the aid of the Centre of Disease Control (CDC), have managed to manufacture vaccines varieties to help in reducing the prevalence of the variation across the globe. As the effort of getting the vaccine proving effective, a number of vaccinations have been made in different countries using various types of COVID-19 vaccines.
Healthcare providers registered several side effects, and complaints were raised by the people who were vaccinated. Various institutions conducted research studies to help reduce the problems to verify the impact of different vaccines on the population (Riad et al., 2021). Scholars run several statistical tests and qualitative analyses to connect the link between age, gender, and underlying health conditions to the COVID-19 vaccine. Based on the study done in the Czech Republic, it is evident that there are serious illnesses and allergies that come when one is vaccinated by the Pfizer-BioNTech covid-19 vaccine. Similar to the study from the US where Moderna was used, and a group of individuals realized changes in their health status.
From the studies, the researchers indicated an effect change, especially after an adult with hypertension has received the first dose vaccination. There tend to be severe problems during the injection of the first dose where some individuals showed instant allergies and body reactions from the vaccines (CDC COVID-19 Response Team, & Food and Drug Administration, 2021). The vaccinated individuals have a different level of adverse effect as this was influence by body weight, age, and health condition.
All the articles concluded that there are severe side effects of the COVID-19 vaccination on people of different ages and gender. Furthermore, there is a correlation between the extent of effects and the state of individual health. The COVID-19 vaccinations showed different signs once injected into the patient’s body (Williams & Dienes, 2021). The side effects after the first dose are less severe compared to those after the second dose on the people having hypertension problems. The studies also show that individuals with allergies are at more risk than those without sensitivities. The articles suggest that vaccine administrators should be aware of the people’s condition before subjecting them to the vaccine.
Amongst the research articles, the definition of the variables of study is different, that is in both dependent and independent variables. Qualitative study articles did not clearly distinguish the variables, thus creating a vague perspective in understanding the instruments (Blumenthal et al., 2021). Unlike quantitative research, authors showed the distinction between the variable, making it easier to understand the realm of the study. Another dissimilarity appears in the choice of data analysis where qualitative gives an overall description with a limited statistical backup which quantitative uses both the statistical tests to prove their explanations. Similarly, quantitative studies provide a strong confidence level on the side effects of the COVID-19 vaccines indicating how hazardous they can be to the public as opposed to the qualitative that fails to provide evidence of the extent of effects.
Finally, the studies converge at some points, especially in giving implications, findings, and a way forward. All the studies indicate the adverse effects after first and second dose injections. They propose that all the healthcare units should have adequate resources to help in managing possible effects of the vaccines like respiratory and heart problems. Lastly, the researchers propose further studies to clearly distinguish between the side effects of the first dose and second dose.
Blumenthal, K. G., Robinson, L. B., Camargo, C. A., Shenoy, E. S., Banerji, A., Landman, A. B., & Wickner, P. (2021). Acute allergic reactions to mRNA COVID-19 vaccines. Jama, 325(15), 1562-1565.
CDC COVID-19 Response Team, & Food and Drug Administration (2021). Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine – United States, 2020-2021. MMWR. Morbidity and mortality weekly report, 70(4), 125–129.
Riad, A., Pokorná, A., Attia, S., Klugarová, J., Koščík, M., & Klugar, M. (2021). Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. Journal of Clinical Medicine, 10(7), 1428.
Williams, S. N., & Dienes, K. A. (2021). Public attitudes to COVID-19 vaccines: A qualitative study. medRxiv. Web.